Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Other
Escitalopram is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for major depressive disorder and generalized anxiety disorder. It works by increasing serotonin levels in the brain to improve mood and emotional balance.
Name
Escitalopram
Raw Name
ESCITALOPRAM OXALATE
Category
Other
Salt Form
Oxalate
Drug Count
7
Variant Count
155
Last Verified
February 17, 2026
RxCUI
351250, 349332, 351249, 351285, 352272, 352273, 404408, 404420, 2725159
UNII
5U85DBW7LO
About Escitalopram
Escitalopram is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for major depressive disorder and generalized anxiety disorder. It works by increasing serotonin levels in the brain to improve mood and emotional balance.
Detailed information about Escitalopram
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Escitalopram.
Escitalopram (marketed under the brand name Lexapro) is a potent medication belonging to the selective serotonin reuptake inhibitor (SSRI) class of antidepressants. According to the FDA-approved labeling, it is the S-enantiomer (a specific molecular mirror image) of the earlier drug citalopram. By isolating the S-enantiomer, researchers developed a compound that targets serotonin transporters with higher specificity and fewer side effects than its racemic predecessor. Escitalopram was first approved by the U.S. Food and Drug Administration (FDA) in 2002 for the treatment of major depressive disorder (MDD) and subsequently in 2003 for generalized anxiety disorder (GAD).
In clinical practice, your healthcare provider may prescribe escitalopram to help restore the balance of certain natural substances, specifically neurotransmitters, in the brain. As an SSRI, it is considered a first-line treatment for various mood and anxiety disorders due to its favorable safety profile and high tolerability compared to older classes of antidepressants, such as tricyclic antidepressants (TCAs) or monoamine oxidase inhibitors (MAOIs). Patients and caregivers should understand that while escitalopram is highly effective, it is not a 'quick fix'; it requires consistent administration over several weeks to achieve therapeutic concentrations and clinical response.
The therapeutic efficacy of escitalopram is primarily attributed to its ability to inhibit the reuptake of serotonin (5-hydroxytryptamine or 5-HT) into the presynaptic neuron. In the human brain, neurons communicate by releasing neurotransmitters into the synaptic cleft (the space between neurons). Serotonin is a key neurotransmitter involved in regulating mood, sleep, appetite, and emotional stability.
At the molecular level, escitalopram binds with high affinity to the human serotonin transporter (SERT). By blocking this transporter, the drug prevents the reabsorption of serotonin, thereby increasing the concentration of the neurotransmitter available in the synaptic cleft. This increased availability allows for prolonged stimulation of post-synaptic serotonin receptors. Over time, this sustained increase in serotonin signaling leads to downstream neuroplastic changes—such as the regulation of neurotrophic factors like BDNF (Brain-Derived Neurotrophic Factor)—which are believed to be the true drivers of antidepressant and anxiolytic (anxiety-reducing) effects. Notably, escitalopram has minimal affinity for other receptors, such as dopamine, norepinephrine, histamine, or muscarinic receptors, which accounts for its lower incidence of sedation, dry mouth, and blurred vision compared to older drugs.
Understanding how the body processes escitalopram is vital for optimizing therapy. The pharmacokinetic profile of escitalopram is characterized by linear, dose-proportional absorption and a predictable elimination pattern.
Escitalopram is FDA-approved for several specific indications, and healthcare providers may also use it 'off-label' for other conditions based on clinical evidence.
Escitalopram is available in several formulations to accommodate different patient needs:
> Important: Only your healthcare provider can determine if Escitalopram is right for your specific condition. A thorough psychiatric and physical evaluation is necessary before starting treatment to ensure the medication is appropriate for your health profile.
The standard starting dose for most adults is 10 mg taken once daily. Depending on the patient's response and tolerability, a healthcare provider may increase the dose to 20 mg once daily after a minimum of one week. In clinical trials for Major Depressive Disorder and Generalized Anxiety Disorder, doses above 20 mg did not consistently demonstrate additional benefit, though they did increase the risk of side effects. For MDD, the therapeutic effect may be seen within 1 to 4 weeks, but the full benefit often takes 8 to 12 weeks of consistent use.
Escitalopram is FDA-approved for the treatment of Major Depressive Disorder in adolescents aged 12 to 17 years. The recommended starting dose is 10 mg once daily. If the dose is increased to 20 mg, it should typically occur after at least three weeks of treatment. Escitalopram has not been established as safe or effective for use in children under the age of 12 for depression, nor is it approved for Generalized Anxiety Disorder in any pediatric population. Close monitoring for suicidal thoughts and behaviors is mandatory in all pediatric patients.
No dosage adjustment is typically required for patients with mild to moderate renal impairment. However, escitalopram should be used with extreme caution in patients with severe renal impairment (Creatinine Clearance < 20 mL/min), as there is limited data on its safety in this population.
For patients with liver disease, the metabolism of escitalopram is slowed. The recommended dose for most patients with hepatic impairment is 10 mg once daily. Healthcare providers will monitor these patients closely for signs of toxicity.
In older adults (65 years and older), the drug remains in the system longer. A maximum recommended dose of 10 mg per day is usually advised for geriatric patients to reduce the risk of side effects like hyponatremia (low blood sodium) and QT prolongation (a heart rhythm issue).
Escitalopram should be taken exactly as prescribed by your doctor. It is typically taken once daily, either in the morning or the evening. Consistency is key; try to take the medication at the same time every day to maintain stable blood levels.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not 'double up' or take two doses at once to make up for a missed one, as this increases the risk of adverse effects.
Signs of an escitalopram overdose may include dizziness, tremors, agitation, rapid heartbeat (tachycardia), seizures, and in severe cases, coma or serotonin syndrome. If an overdose is suspected, contact emergency services (911 in the U.S.) or a poison control center immediately. Emergency treatment often involves supportive care, gastric lavage (stomach pumping), and the administration of activated charcoal to prevent further absorption.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, as sudden discontinuation can lead to withdrawal symptoms.
Most patients taking escitalopram will experience some mild side effects, particularly during the first two weeks of treatment as the body adjusts to the medication. Common side effects include:
> Warning: Stop taking Escitalopram and call your doctor immediately or seek emergency care if you experience any of the following:
With prolonged use, some patients may experience 'emotional blunting,' where they feel less intense emotions (both positive and negative). There is also evidence suggesting that long-term use of SSRIs may be associated with a slight decrease in bone mineral density, increasing the risk of fractures in older populations. Weight gain is also a common concern for long-term users, though it varies significantly between individuals.
Escitalopram carries an FDA Black Box Warning regarding Suicidality and Antidepressant Drugs. Clinical data has shown that antidepressants increase the risk of suicidal thinking and behavior in children, adolescents, and young adults (ages 18-24) during initial treatment. Healthcare providers must weigh this risk against the clinical need. Families and caregivers should be advised of the need for close observation and communication with the prescriber if any changes in behavior, worsening of depression, or suicidal thoughts occur. This drug is not approved for use in pediatric patients under 12 years of age.
Report any unusual symptoms or persistent side effects to your healthcare provider immediately. Many side effects can be managed with dose adjustments or supportive care.
Escitalopram is a powerful psychoactive medication that requires careful medical supervision. It is not suitable for everyone, and certain pre-existing conditions can increase the risk of dangerous complications. Patients must provide a full medical history to their doctor, including any history of heart problems, seizures, liver or kidney disease, or bipolar disorder.
Suicidality in Children, Adolescents, and Young Adults: The FDA requires a boxed warning on all SSRIs, including escitalopram, because of the increased risk of suicidal thoughts and actions in patients under the age of 25. This risk is highest during the first few months of treatment or when the dose is changed. Patients of all ages should be monitored for signs of worsening depression, agitation, or unusual changes in behavior.
Your healthcare provider may require periodic monitoring while you are taking escitalopram:
Escitalopram may cause dizziness or drowsiness, particularly when you first start taking it. Do not drive, operate heavy machinery, or perform dangerous tasks until you know how this medication affects you. Your reaction time and judgment may be impaired.
While clinical studies have not shown escitalopram to increase the impairment caused by alcohol, it is generally recommended to avoid alcohol while taking antidepressants. Alcohol can worsen symptoms of depression and anxiety and may increase the sedative effects of the medication.
Never stop taking escitalopram abruptly. Sudden discontinuation can lead to Discontinuation Syndrome (sometimes called FINISH syndrome). Symptoms include:
To avoid these symptoms, your doctor will provide a tapering schedule to gradually reduce the dose over several weeks.
> Important: Discuss all your medical conditions and concerns with your healthcare provider before starting Escitalopram to ensure the safest possible treatment plan.
Certain medications should never be taken with escitalopram due to the risk of life-threatening reactions.
Escitalopram does not typically interfere with common laboratory tests, but it may cause false-positive results in some urine drug screens for benzodiazepines or other substances depending on the specific assay used. Always inform laboratory personnel and your doctor that you are taking this medication.
Mechanism of Interaction: Most interactions occur through either pharmacodynamic synergy (two drugs having the same effect, like increasing serotonin) or pharmacokinetic competition (drugs competing for the same CYP450 liver enzymes).
> Important: Tell your doctor about ALL medications, over-the-counter drugs, vitamins, and herbal products you are taking. A complete list is necessary to prevent dangerous interactions.
Absolute contraindications are conditions or situations where the risk of using escitalopram clearly outweighs any possible benefit, and the drug must not be used.
Relative contraindications require a careful risk-benefit analysis by a healthcare professional. Escitalopram may be used, but with extreme caution and increased monitoring.
Patients who have had a severe adverse reaction to citalopram (Celexa) are highly likely to have a similar reaction to escitalopram, as escitalopram is the active component of citalopram. Cross-sensitivity between different classes of antidepressants (e.g., between an SSRI and a TCA) is less common but should still be considered by your doctor.
> Important: Your healthcare provider will evaluate your complete medical history, including any previous reactions to medications, before prescribing Escitalopram. Always be honest about your health history.
Escitalopram is classified as Pregnancy Category C under the older FDA system. Data regarding its use during pregnancy is complex.
Escitalopram is excreted into human breast milk. While the amounts are generally low, there have been reports of excessive somnolence (sleepiness) and decreased feeding in nursing infants. If a mother continues escitalopram while breastfeeding, the infant should be monitored closely for these symptoms. For many women, the benefits of breastfeeding and the benefits of maternal mental health outweigh the small risks to the infant.
Escitalopram is FDA-approved for Major Depressive Disorder in adolescents aged 12 to 17. It is not approved for children under 12 or for Generalized Anxiety Disorder in any pediatric age group. The primary concern in this population is the increased risk of suicidal ideation. Growth (weight and height) should be monitored, as some studies suggest SSRIs may slightly delay growth, though most children eventually catch up.
In patients over 65, escitalopram levels can be up to 50% higher than in younger adults. This increases the risk of:
No dosage adjustment is needed for mild to moderate impairment. In severe cases (CrCl < 20 mL/min), the drug should be used with caution as it has not been adequately studied in this group.
For patients with any degree of liver impairment, the recommended dose is 10 mg per day. The liver is the primary site of metabolism, and impaired function leads to higher drug concentrations and increased risk of toxicity.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Escitalopram is the S-enantiomer of the racemic bicyclic phthalane derivative citalopram. Its primary mechanism of action is the highly selective inhibition of the presynaptic serotonin transporter (SERT). By binding to the primary site on the SERT protein, it prevents the reuptake of serotonin (5-HT) into the presynaptic terminal.
Unique to escitalopram is its 'allosteric' mechanism. It binds to a secondary (allosteric) site on the serotonin transporter, which stabilizes the binding of the drug at the primary site. This dual-binding mechanism results in a more potent and sustained inhibition of serotonin reuptake compared to other SSRIs. Escitalopram has very little to no affinity for other transporters (norepinephrine or dopamine) or for various receptors (cholinergic, histaminergic, or adrenoceptors), which contributes to its clean side-effect profile.
The clinical effects of escitalopram are not immediate. While the inhibition of serotonin reuptake occurs shortly after the first dose, the antidepressant effect requires chronic administration. This is thought to be due to the desensitization of inhibitory 5-HT1A autoreceptors, which eventually allows for a sustained increase in serotonin release and improved neurotransmission. There is a clear dose-response relationship for side effects, but for many patients, 10 mg provides the optimal balance of efficacy and tolerability.
| Parameter | Value |
|---|---|
| Bioavailability | ~80% |
| Protein Binding | ~56% |
| Half-life | 27–32 hours |
| Tmax | ~5 hours |
| Metabolism | Hepatic (CYP2C19, CYP3A4) |
| Excretion | Renal (7%), Fecal (trace) |
Escitalopram is classified as a Selective Serotonin Reuptake Inhibitor (SSRI). Related medications in this class include fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), and citalopram (Celexa). Among these, escitalopram is often cited as the most selective for the serotonin transporter.
Medications containing this ingredient
Common questions about Escitalopram
Escitalopram is primarily FDA-approved for the treatment of Major Depressive Disorder (MDD) in adults and adolescents aged 12 to 17, as well as Generalized Anxiety Disorder (GAD) in adults. It is a member of the selective serotonin reuptake inhibitor (SSRI) class, which works by increasing the levels of serotonin in the brain to help improve mood and reduce anxiety. Beyond these approved uses, healthcare providers may prescribe it 'off-label' for conditions such as social anxiety disorder, panic disorder, obsessive-compulsive disorder (OCD), and post-traumatic stress disorder (PTSD). It is valued in the medical community for having a high degree of selectivity, meaning it affects serotonin more specifically than other neurotransmitters, often leading to fewer side effects than older antidepressants. Treatment is typically long-term, and patients should expect to take the medication for several months to years as directed by their doctor.
The most common side effects of escitalopram include nausea, insomnia, increased sweating, fatigue, and sexual dysfunction. Nausea is particularly frequent during the first week of treatment but usually subsides as the body adjusts to the medication. Sexual side effects, such as decreased libido or delayed ejaculation, are also common and may persist for the duration of treatment. Some patients may also experience dry mouth, drowsiness, or a slight increase in appetite. While most of these effects are mild and manageable, it is important to report any persistent or bothersome symptoms to your healthcare provider. They may be able to adjust your dose or suggest ways to mitigate these effects, such as taking the medication with food to reduce stomach upset.
It is generally recommended that patients avoid or strictly limit alcohol consumption while taking escitalopram. Although clinical studies have not shown that escitalopram significantly increases the cognitive or motor impairment caused by alcohol, combining the two can still be problematic. Alcohol is a central nervous system depressant that can worsen the symptoms of depression and anxiety, effectively working against the benefits of the medication. Furthermore, both alcohol and escitalopram can cause drowsiness and dizziness, and combining them may increase these sedative effects, making activities like driving dangerous. If you choose to drink, you should discuss it with your doctor first to understand your individual risks based on your health history and dosage.
The safety of escitalopram during pregnancy is a complex issue that requires a detailed discussion with a healthcare provider. Escitalopram is classified in a way that suggests potential risks, particularly when taken during the third trimester. Use late in pregnancy has been associated with neonatal adaptation syndrome, where the newborn may experience irritability, tremors, or breathing difficulties, as well as a rare but serious condition called persistent pulmonary hypertension of the newborn (PPHN). However, leaving major depression untreated during pregnancy also poses significant risks to both the mother and the developing fetus, including premature birth and low birth weight. Therefore, doctors often perform a risk-benefit analysis to decide whether the benefits of maintaining the mother's mental health outweigh the potential risks to the baby.
Escitalopram does not work immediately; it typically takes several weeks for patients to feel the full therapeutic benefits. Some patients may notice slight improvements in sleep, energy, or appetite within the first 1 to 2 weeks, which are positive signs that the medication is starting to work. However, the core symptoms of depression or anxiety, such as low mood or excessive worry, usually take 4 to 6 weeks—and sometimes up to 8 to 12 weeks—to significantly improve. It is crucial to continue taking the medication exactly as prescribed even if you do not feel better right away. If you have not noticed any improvement after 6 to 8 weeks of consistent use, you should consult your doctor, as they may need to adjust your dose or consider a different medication.
No, you should never stop taking escitalopram suddenly, as this can lead to a range of uncomfortable withdrawal symptoms known as discontinuation syndrome. These symptoms can include dizziness, 'brain zaps' (sensory disturbances that feel like electric shocks), nausea, sweating, irritability, and vivid dreams. To safely stop the medication, your healthcare provider will create a tapering schedule, which involves gradually reducing your dose over a period of several weeks or even months. This allows your brain's chemistry to slowly readjust to the decreasing levels of the drug. If you wish to stop taking escitalopram, always consult your doctor first so they can guide you through a safe and monitored tapering process.
If you miss a dose of escitalopram, you should take it as soon as you remember. However, if it is nearly time for your next scheduled dose, you should skip the missed dose and simply take the next one at your regular time. You should never take two doses at once to make up for a missed one, as this can increase the risk of side effects or toxicity. Maintaining a consistent level of the medication in your bloodstream is important for its effectiveness, so try to take it at the same time every day. If you find yourself frequently forgetting doses, consider using a pill organizer or setting a daily alarm on your phone to help you stay on track.
Weight changes are a known potential side effect of escitalopram and other SSRIs, though the effect varies significantly from person to person. Some clinical studies suggest that while short-term use (less than 6 months) may result in minimal weight change or even slight weight loss, long-term use can be associated with modest weight gain in some patients. This gain may be due to the medication's effect on metabolism or because an improved mood leads to an increased appetite. If you are concerned about weight gain, it is helpful to monitor your diet and maintain a regular exercise routine. If significant weight gain occurs, discuss it with your doctor, as they may suggest strategies to manage it or evaluate if a different medication is appropriate.
Escitalopram can interact with many other medications, so it is vital to inform your doctor of everything you are taking, including over-the-counter drugs and herbal supplements. It should never be taken with MAOIs or pimozide due to the risk of life-threatening reactions. Caution is also required when taking it with other serotonergic drugs (like triptans for migraines or St. John's Wort) because of the risk of Serotonin Syndrome. Additionally, because escitalopram can increase the risk of bleeding, you should be careful when taking it with blood thinners, aspirin, or NSAIDs like ibuprofen. Your doctor will check for these and other potential interactions to ensure that escitalopram is safe for you to use alongside your other treatments.
Yes, escitalopram is widely available as a generic medication and is the generic version of the brand-name drug Lexapro. Generic medications are required by the FDA to have the same active ingredient, strength, dosage form, and route of administration as the brand-name version. They must also prove 'bioequivalence,' meaning they work in the body in the same way and over the same amount of time. Generic escitalopram is typically much less expensive than Lexapro, making it a more accessible option for many patients. Most insurance plans cover the generic version, and you can expect the same therapeutic results regardless of whether you take the brand-name or the generic form.